NovaDel Pharma makes appointment
This article was originally published in Scrip
Executive Summary
NovaDel Pharma (US) has appointed Craig Johnson senior vice-president, chief financial officer and secretary. The company's chairman, president and chief executive officer, Steven Ratoff, had been serving interim CFO and secretary since April 2009. Mr Johnson served as vice-president and CFO of TorreyPines Therapeutics from 2004 until its sale to Raptor Pharmaceutical in September 2009. Following the sale, he was vice-president of TPTX, a subsidiary of Raptor, until April this year. NovaDel is a speciality pharmaceutical company developing oral spray formulations for a range of marketed drugs.